Aurora Cannabis (ACB) Non Operating Investment Income (2017 - 2022)
Aurora Cannabis (ACB) posted quarterly Non Operating Investment Income of -$1.5 million for Q4 2022, down 130.6% year-on-year from $4.8 million in Q4 2021, and down 10.7% on a QoQ basis from -$1.3 million in Q3 2022.
Aurora Cannabis (ACB) Non Operating Investment Income (2017 - 2022) Analysis & Trends
Aurora Cannabis (ACB) has reported Non Operating Investment Income for 6 consecutive years, with -$1.5 million the latest figure, recorded in Q4 2022.
- Quarterly Non Operating Investment Income fell 130.6% year-over-year to -$1.5 million in Q4 2022, while the trailing twelve-month figure through Dec 2022 was -$3.1 million (up 62.15% YoY) and the FY2022 annual result came in at -$776138.5, up 93.02% from the prior year.
- Non Operating Investment Income fell to -$1.5 million in Q4 2022 per ACB's latest filing, from -$1.3 million in the prior quarter.
- Over the last five years, Non Operating Investment Income for ACB reached as high as $147.2 million in Q4 2018 and fell as low as -$14.5 million in Q3 2019.
- A 5-year average of $14.1 million and a median of -$748950.7 in 2021 frame the typical range for Non Operating Investment Income.
- Annual changes were most pronounced in 2018 — Non Operating Investment Income jumped 1111.23% — and 2021, when it sank 205.17%.
- Year by year, Non Operating Investment Income stood at $147.2 million in 2018, then slumped by 105.91% to -$8.7 million in 2019, then jumped by 40.52% to -$5.2 million in 2020, then soared by 87.65% to -$638635.5 in 2021, then sank by 130.6% to -$1.5 million in 2022.
- According to Business Quant data, Non Operating Investment Income over the past three periods registered -$1.5 million, -$1.3 million, and -$770222.5 for Q4 2022, Q3 2022, and Q2 2022 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Investment Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.86 Bn | 88.00 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.89 Bn | 32.15 Bn | 1.97 Bn | - |
| 3 | Zoetis | 32.57 Bn | 30.63 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 27.54 Bn | 23.48 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.06 Bn | 20.90 Bn | 648.10 Mn | - |
| 6 | RedHill Biopharma | 21.48 Bn | 21.48 Bn | - | - |
| 7 | Viatris | 20.43 Bn | 18.62 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.81 Bn | 16.49 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.61 Bn | 12.18 Bn | 785.00 Mn | - |
| 10 | Aurora Cannabis | 155.11 Mn | 69.87 Mn | 21.72 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | -1.47 Mn |
| Dec 31, 2022 | -1.47 Mn |
| Sep 30, 2022 | -1.33 Mn |
| Sep 30, 2022 | -1.33 Mn |
| Jun 30, 2022 | -770,222.52 |
| Jun 30, 2022 | -770,222.52 |
| Mar 31, 2022 | 502,106.36 |
| Mar 31, 2022 | 502,106.36 |
| Dec 31, 2021 | -638,635.55 |
| Dec 31, 2021 | -638,635.55 |
| Sep 30, 2021 | -727,678.93 |
| Sep 30, 2021 | -727,678.93 |
| Jun 30, 2021 | -7.88 Mn |
| Jun 30, 2021 | -7.88 Mn |
| Mar 31, 2021 | 1.13 Mn |
| Mar 31, 2021 | 1.13 Mn |
| Dec 31, 2020 | -5.17 Mn |
| Dec 31, 2020 | -5.17 Mn |
| Sep 30, 2020 | 691,890.62 |
| Sep 30, 2020 | 691,890.62 |